• Investors may be wondering whether Ducommun, at its recent close of around US$141.48, still offers value or whether most of the opportunity is already reflected in the price.
• The stock has posted returns of 0.1% over the last week, 17.3% over the last month, 46.2% year to date and 157.6% over the past year, with 3 year and 5 year returns of 179.1% and 143.9% respectively.
• Recent coverage has focused on Ducommun's role within the capital goods sector and investor interest in companies exposed to aerospace and defense related demand. This context helps explain why the share price has been closely watched as investors reassess growth prospects and risk.
• Simply Wall St's valuation model currently gives Ducommun a valuation score of 4 out of 6. This raises questions about how traditional methods such as discounted cash flow models and valuation multiples compare with a more complete way of thinking about value that will be covered at the end of this article.

Approach 1: Ducommun Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a business might be worth today by projecting its future cash flows and then discounting those back to a present value.

For Ducommun, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections in $. The latest twelve month free cash flow is a loss of $50.43 million. Analysts provide explicit forecasts out to 2028, with free cash flow for that year projected at $108.62 million. Simply Wall St then extrapolates further to 2035, with discounted free cash flow estimates each year between 2026 and 2035.

Adding these discounted cash flows together, along with a terminal value, leads to an estimated intrinsic value of around $203.08 per share. Compared with the recent share price of about $141.48, the model implies the stock trades at a 30.3% discount, suggesting Ducommun screens as undervalued on this DCF view.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Ducommun is undervalued by 30.3%. Track this in your watchlist or portfolio, or discover 58 more high quality undervalued stocks.

Approach 2: Ducommun Price vs Sales

For companies where earnings are less meaningful or volatile, the price to sales, or P/S, ratio is often a useful yardstick because it compares the share price with the revenue the business generates, rather than focusing on profits alone.

What counts as a reasonable P/S ratio depends on how quickly investors expect revenue to grow and how much risk they see in those expectations. Higher growth and lower perceived risk can support a higher P/S multiple, while slower growth or higher uncertainty usually point to a lower one.

Ducommun currently trades on a P/S ratio of 2.57x. That sits below the Aerospace & Defense industry average P/S of 5.31x and also below the peer group average of 5.19x. Simply Wall St’s Fair Ratio for Ducommun is 1.19x, which is a proprietary estimate of the P/S multiple that might be appropriate given factors such as earnings growth, industry, profit margins, market cap and company specific risks.

This Fair Ratio can be more informative than a simple comparison with peers or the industry because it adjusts for the company’s own growth profile, risk characteristics and profitability. With the current 2.57x P/S ratio above the 1.19x Fair Ratio, Ducommun screens as overvalued on this metric.

Result: OVERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Ducommun Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Meet Narratives, a simple tool on Simply Wall St’s Community page that lets you set out your own story for Ducommun by linking assumptions about future revenue, earnings, margins and a fair value to that story. You can then compare your fair value with the current price to help decide when the stock looks attractive or expensive. Each Narrative updates automatically as new information like earnings or news is added. One investor might build a Ducommun Narrative around the analyst consensus fair value of US$143.20 and the earnings and margin assumptions behind it, while another might plug in a more cautious or more optimistic view. You can see both side by side and decide which story you find more convincing.

Do you think there's more to the story for Ducommun? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.